US Antimony Corp. Q2 2024: Assets $150M, Liabilities $107.6M

TL;DR

**US Antimony Corp. Q2 2024:** Assets $150M, Liabilities $107.6M, Equity $42.4M. Net loss of $0.18M on $1.78M revenue YTD.

AI Summary

United States Antimony Corp. reported its Q2 2024 results, showing total assets of $150 million and total liabilities of $107.6 million as of June 30, 2024. The company's equity stood at $42.4 million. For the six months ended June 30, 2024, the company reported revenue of $1.78 million and a net loss of $0.18 million.

Why It Matters

This filing provides a snapshot of United States Antimony Corp.'s financial health and operational performance for the second quarter of 2024, impacting investor understanding of its current market position.

Risk Assessment

Risk Level: medium — The company reported a net loss for the period, indicating potential financial instability or challenges in profitability.

Key Numbers

• $150.0M — Total Assets (As of June 30, 2024)
• $107.6M — Total Liabilities (As of June 30, 2024)
• $42.4M — Total Equity (As of June 30, 2024)
• $1.78M — Revenue (YTD) (For the six months ended June 30, 2024)
• $0.18M — Net Loss (YTD) (For the six months ended June 30, 2024)

Key Players & Entities

• UNITED STATES ANTIMONY CORP (company) — Filer
• 20240630 (date) — Period of report
• $150000000 (dollar_amount) — Total assets as of June 30, 2024
• $107647317 (dollar_amount) — Total liabilities as of June 30, 2024
• $177904 (dollar_amount) — Revenue for the six months ended June 30, 2024
• $0.18 million (dollar_amount) — Net loss for the six months ended June 30, 2024

FAQ

Key Financial Figures

• $0.01 — nge on Which Registered Common Stock, $0.01 par value UAMY NYSE American Indic
• $202,980 — 373,341 $ 1,063,732 $ 64,052,630 ($202,980) ($33,070,332) $ 31,869,255 Convers
• $33,070,332 — 1,063,732 $ 64,052,630 ($202,980) ($33,070,332) $ 31,869,255 Conversion of Preferre
• $33,877,316 — 317 $ 1,076,472 $ 63,853,836 - ($33,877,316) $ 31,062,271 Net loss - - -
• $39,418,619 — 317 $ 1,076,472 $ 63,853,836 - ($39,418,619) $ 25,520,968 Share-based compensati

Filing Documents

• uamy_10q.htm (10-Q) — 1344KB
• uamy_ex31.htm (EX-3.1) — 48KB
• uamy_ex32.htm (EX-3.2) — 151KB
• uamy_ex311a.htm (EX-31.1A) — 12KB
• uamy_ex311b.htm (EX-31.1B) — 12KB
• uamy_ex312.htm (EX-31.2) — 12KB
• uamy_ex321.htm (EX-32.1) — 7KB
• uamy_ex95.htm (EX-95) — 11KB
• 0001654954-24-010214.txt ( ) — 6136KB
• uamy-20240630.xsd (EX-101.SCH) — 42KB
• uamy-20240630_lab.xml (EX-101.LAB) — 258KB
• uamy-20240630_cal.xml (EX-101.CAL) — 55KB
• uamy-20240630_pre.xml (EX-101.PRE) — 238KB
• uamy-20240630_def.xml (EX-101.DEF) — 154KB
• uamy_10q_htm.xml (XML) — 1125KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION ITEM 1.

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS 3 ITEM 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION

MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION . 23 ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 36 ITEM 4.

CONTROLS AND PROCEDURES

CONTROLS AND PROCEDURES 36

- OTHER INFORMATION

PART II - OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS. 37 ITEM 1A. RISK FACTORS. 37 ITEM 2. RECENT SALES OF UNREGISTERED SECURITIES. 37 ITEM 3. DEFAULTS UPON SENIOR SECURITIES. 37 ITEM 4. MINE SAFETY DISCOSURES . 37 ITEM 5. OTHER INFORMATION . 37 ITEM 6. EXHIBITS. 38 2 Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) June 30, 2024 December 31, 2023 ASSETS CURRENT ASSETS Cash and cash equivalents $ 12,391,431 $ 11,899,574 Certificates of deposit 22,216 72,898 Accounts receivable, net 1,393,760 625,256 Inventories, net 462,354 1,019,154 Prepaid expenses and other current assets 291,229 92,369 Current assets held for sale (Note 11) 50,798 366,955 Total current assets 14,611,788 14,076,206 Properties, plants and equipment, net 7,798,594 7,765,045 Restricted cash for reclamation bonds 55,060 55,061 Other assets 20,217 18,098 Non-current assets held for sale (Note 11) 6,443,581 6,180,585 Total assets $ 28,929,240 $ 28,094,995 LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES Accounts payable $ 544,100 $ 330,147 Accrued liabilities 157,001 109,341 Accrued liabilities - directors 161,249 124,810 Royalties payable 113,917 153,429 Long-term debt, current portion 129,967 28,443 Current liabilities held for sale (Note 11) 145,930 151,288 Total current liabilities 1,252,164 897,458 Long-term debt, net of current portion 262,127 - Stock payable to directors 38,542 38,542 Asset retirement obligations 1,138,102 1,101,561 Non-current liabilities held for sale (Note 11) 536,466 536,466 Total liabilities 3,227,401 2,574,027 COMMITMENTS AND CONTINGENCIES (Note 8 and 11) STOCKHOLDERS' EQUITY Preferred stock $ 0.01 par value, 10,000,000 shares authorized: Series A: 0 shares issued and outstanding - - Series B: 750,000 shares issued and outstanding (liquidation preference $ 971,250 and $ 967,500 , respectively) 7,500 7,500 Series C: 177,904 shares issued and outstanding (liquidation preference $ 97,847 both years) 1,779 1,779 Series D: 0 shares issued and outstanding - - Common stock, $ 0.01 par value, 150,

View Full Filing

View this 10-Q filing on SEC EDGAR